Architectural Heterogeneity in Tumors Caused by Differentiation
Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound
Figure 4
Change in relative vascular permeability and vascular volume as a result of treatment with MSC in H69 (a), A549 (b), A253 (c), PDSCC (d), and WDSCC (e) tumors as assessed by DCE-MRI.
